The Chamber | For a Greater Chapel Hill-Carrboro

GOVERNMENT BUSINESS

OmniSync | February 25, 2022

OmniSync Incorporated announces the successful completion of the period of performance under its second innovation contract from the US Air Force, fully meeting the objectives of both contracts. OmniSync is a San Diego-based high-growth tech startup that uses a combination of AI/ML-powered research tools, process workflow automation, and services to help democratize access to government grant and contract funds. Its flagship product, TurboSBIR is used by hundreds of deep tech and ...

GOVERNMENT BUSINESS

Sev1Tech | October 26, 2021

Sev1Tech, LLC, a leading provider of IT modernization, cybersecurity, and cloud services to both federal and commercial customers, announced today that it completed the acquisition of Geocent, LLC. Geocent serves the U.S. federal government through its strong reputation as an innovator in DevSecOps and engineering services, supporting critical missions across agencies. Both Sev1Tech and Geocent are familiar and valued partners to the government agencies and commercial organization...

Google | July 03, 2020

Google, IBM and Microsoft have joined with top research universities to prod the federal government to create a nationwide shared cloud-computing platform, saying it is urgently needed to keep the U.S. from falling behind foreign competitors. A national research cloud would open the doors of Big Tech companies’ data to academic outsiders. It could mean that companies such as Google would hand over the keys to data collected during the coronavirus crisis, such as details on users’ mov...

JOHNSON & JOHNSON | March 31, 2020

The Trump administration has made another move in the race to combat and stop the viral outbreak of COVID-19, also known as the coronavirus, around the globe. The Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) recently signed a deal for a $456 million order with Johnson & Johnson’s Pharmaceuticals arm Janssen. The order has been specified as a “new vaccine asset for 2019 Novel Coronavirus (COVID-19).” It is the largest amoun...